We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Syphilis Diagnosed Quickly and Easily Worldwide

By HospiMedica staff writers
Posted on 19 Jan 2007
A point-of-care test that is accurate, fast, flexible, and easy to use helps control, through rapid diagnosis and treatment, the threat of syphilis in even the most remote areas of the world.

With more than 12 million new cases of syphilis being diagnosed annually worldwide, it remains a serious public health threat. More...
Although 90% of cases are in the developing world, incidences of the disease are rising rapidly in Europe and North America. If left untreated, syphilis can become chronic, eventually leading to irreversible damage to the heart and nervous system.

Rapid point-of-care tests for syphilis is one of the main priorities World Health Organization's (WHO, Geneva, Switzerland) Sexually Transmitted Diseases (STDs) Diagnostics Initiative (SDI). The SDI is promoting the development and evaluation of rapid diagnostic tests that are affordable, highly sensitive and specific, simple to use, rapid, robust, and equipment free.

Traditional methods of detecting and diagnosing syphilis have a number of disadvantages. Obtaining patient samples can be uncomfortable and inconvenient, some methods are susceptible to false-positives, others require confirmatory tests and many procedures need laboratory equipment and trained staff--two things that are often lacking in many areas of the world where 90% of syphilis cases occur.

Rapid testing, diagnosis and treatment can not only help pregnant women but also identify and treat other patients with suspicious clinical lesions, which aids healthcare workers in reducing the risk of syphilis and other STIs spreading amongst their patient communities.

Determine Syphilis from Inverness Medical (Waltham, MA, USA) provides results in just 15 minutes, ensuring that diagnosis and commencement of treatment can occur in the same visit. A simple one-step procedure for serum/plasma, or two-step for whole blood, Determine Syphilis Treponema pallidum (TP) is very easy to use and interpret, requiring minimal training. In clinical trials it demonstrated excellent sensitivity using serum and high accuracy using whole blood and paired serum and plasma.



Related Links:
World Health Organization
Inverness Medical

New
Gold Member
Breast Imaging Monitor
Barco Coronis Onelook MDMC-32133 32MP
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Tourniquet System
heidi– mein Tourniquet
Hybrid Arch Device
Neo EDE
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: New findings show that chemotherapy plus immunotherapy before surgery produced greater tumor destruction than immunotherapy alone in head and neck cancer patients (Image Credit: Adobe Stock)

Combination Therapy Before Surgery Drives Stronger Tumor Reduction in Head and Neck Cancer

Patients with head and neck cancer who are scheduled for surgery often face a waiting period with limited treatment, creating an opportunity to reduce viable tumor burden before the operation.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.